Ultrasound AI’s Preterm AI Receives Its First Patent on International Women’s Day
Next Gen AI-Powered Medical Technology Seeks to Revolutionize Obstetric Care by Predicting Preterm Birth and Pregnancy Complications in Time for Earlier Interventions
HIGHLANDS RANCH, Colo., March 28, 2022 (GLOBE NEWSWIRE) -- Ultrasound AI™, Inc., an artificial intelligence company dedicated to improving women’s health, today announces that they were awarded their first patent on International Women’s Day for the software powering their groundbreaking predictive diagnostic medical technology, Preterm AI™ (PAI). PAI combines the power of ultrasound with artificial intelligence to predict preterm birth.
The U.S. patent application states PAI’s software has been applied to real-world data obtained from a clinical context and has been shown to consistently produce a positive predictive value (the AI predicts a preterm birth, and the mother then delivers preterm) above 90% and a negative predictive value (the AI predicts a normal birth, and then the mother delivers the baby at full term) above 90%.
"This technology has the potential to revolutionize obstetric care as well as accelerate research to develop new interventions to prevent both premature births and miscarriages," said Dr. Garrett K. Lam, FACOG, Chief Medical Officer at Ultrasound AI.
Preterm birth is when a baby is born before 37 weeks of pregnancy. In 2020, preterm birth affected one in 10 infants born in the United States.1 Preterm birth complications are the leading cause of death among children under five years of age, responsible for approximately one million deaths annually.2 Premature births often result in emotional trauma for families, prolonged stays in specialty care nurseries, and profound health consequences for preterm infants.3 Many women who deliver prematurely have no known risk factors or early symptoms of complications.4
“Doctors assume 280 days until birth, and they may be able to label someone as ‘at risk,’ but that isn’t necessarily accurate. The ability to accurately predict if a baby will be born early and how early are non-existent using ultrasound imaging. The current blood tests are limited in use and accuracy, and can be expensive,” explains Robert Bunn, President and Founder of Ultrasound AI.
Bunn is the pioneering expertise behind this discovery. After he and his wife experienced nine miscarriages and the happy arrival of four daughters over time, he knew he wanted to “make a huge dent in every serious affliction that only impacts women.” He used AI to analyze the data from 400,000+ de-identified ultrasound images. The AI learned patterns from those images and was eventually able to recognize patterns in images and associate them with birth outcomes.
“There’s a lot of noise in the images in ultrasound, so humans have difficulty seeing the image and understanding it. Our AI software is trained to do what we can’t and see things that we can’t see. Most people wouldn’t even consider this possible,” shared Bunn.
Now, after four years of cutting-edge research and development, this revolutionary new AI software shows the promise to change the lives of countless families around the world. PAI has the power to give providers and patients timely, accurate information to make better-informed decisions and improve the wellbeing of babies and mothers.
About Ultrasound AI, Inc.
Founded in 2019, Ultrasound AI™ is a cloud-based artificial intelligence company whose innovations rely on the power of AI combined with ultrasound imaging. Improving the lives of women is 100% of the focus of Ultrasound AI, whose first expected product, Preterm AI™, has the power to predict preterm birth. To learn more, visit www.preterm.ai or connect with the team on Facebook, Twitter, or LinkedIn. Preterm AI is not currently FDA approved.
1 Centers for Disease Control and Prevention. (2021, November 1). Preterm birth. Centers for Disease Control and Prevention. Retrieved March 23, 2022, from https://www.cdc.gov/reproductivehealth/maternalinfanthealth/pretermbirth.htm
2 World Health Organization. Preterm birth. World Health Organization. Retrieved March 23, 2022, from https://www.who.int/news-room/fact-sheets/detail/preterm-birth
3 Lakshmanan, A., Agni, M., Lieu, T., Fleegler, E., Kipke, M., Friedlich, P. S., McCormick, M. C., & Belfort, M. B. (2017, February 16). The impact of preterm birth <37 weeks on parents and families: A cross-sectional study in the 2 years after discharge from the Neonatal Intensive Care Unit. Health and quality of life outcomes. Retrieved March 23, 2022, from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5312577/
4 Mayo Foundation for Medical Education and Research. (2021, April 14). Premature birth. Mayo Clinic. Retrieved March 23, 2022, from https://www.mayoclinic.org/diseases-conditions/premature-birth/symptoms-causes/syc-20376730
(714) 573-0899 ext. 230
Upcoming Life Sciences Events
- July 2022
- Piscataway: Bio-Manufacturing Innovation Summit
- BIO Asia-Taiwan
- August 2022
- Biotechgate Digital Partnering August 2022